Kay T. Yeung, Claudine Isaacs, Marissa Howard-Mcnatt, Christina Yau, Jo Chien, Anne M. Wallace, Judy Caroline Boughey, Hyo S. Han, Virginia F. Borges, Carla Isadora Falkson, Douglas Yee, Coral Omene, Rita Nanda, Andrew Chapple, Jane Perlmutter, Paula R. Pohlmann, Alexander D. Borowsky, W. Fraser Symmans, Laura van't Veer, Laura Esserman. "Neoadjuvant DAN-222 plus niraparib in high-risk HER2-negative breast cancer: Results from the I-SPY 2 adaptive platform trial.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.625